Filter
151
Text search:
Pharmacology
Featured
Recommendations
18
New Publications
29
Language
Document type
No document type
75
Guidelines
31
Studies & Reports
27
Manuals
8
Training Material
4
Fact sheets
2
Brochures
1
Situation Updates
1
Resource Platforms
1
Strategic & Response Plan
1
Countries / Regions
India
11
South Africa
9
Ethiopia
5
Global
5
Kenya
4
Rwanda
4
Nigeria
3
Syria
3
Latin America and the Carribbean
3
Africa
3
Russia
3
Uganda
2
Zimbabwe
2
Nepal
2
Tanzania
2
Bangladesh
2
Malawi
2
Western and Central Europe
2
Burkina Faso
1
Sierra Leone
1
USA
1
Iraq
1
Thailand
1
China
1
Sudan
1
Argentina
1
Namibia
1
Eswatini/ Swaziland
1
Ukraine
1
Botswana
1
Bolivia
1
East and Southern Africa
1
Asia
1
Eastern Europe
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
50
Clinical Guidelines
18
Public Health
11
Women & Child Health
4
Pharmacy & Technologies
4
Key Resources
1
Toolboxes
Pharmacy
20
Mental Health
14
AMR
14
HIV
13
TB
8
COVID-19
8
Caregiver
5
NCDs
5
Specific Hazards
4
Conflict
3
NTDs
3
Disability
2
Ebola & Marburg
2
Natural Hazards
1
Planetary Health
1
Accessed on 15.08.2022
La farmacovigilancia es una herramienta que permite la detección, evaluación, conocimiento y prevención de efectos adversos y/o inesperados de los medicamentos que se prescriben. También facilita la detección de fallas de respuesta terapéutica por deficiencias de calid
...
The MSF qualification scheme is concerned with the pharmaceutical quality assessment for drugs. This procedure is applicable to products for international supply, i.e. products supplied through the MSF procurement centres. This qualification procedure is not applicable for local purchase, i.e. purch
...
BUKO Pharma-Kampagne has investigated the causes and consequences of antibiotic resistance in India, South Africa, Tanzania and Germany. Together with our partners we collected data and did interviews with numerous stakeholders. The outcome is presented in a brochure that is now available in English
...
The Pharmaceutical Forum of the Americas (PFA) has previously published guidelines and organised campaigns for community pharmacists on the prevention, detection and control of arbovirus infections in 2018 with a grant from the FIP Foundation for Pharmacy Education and Research. Building on that exp
...
Q9: What is/are the effective and safe interventions to treat somatoform disorders in children and adolescents in non- specialist health settings?
WHO Technical Report Series, No. 961, 2011, Annex 8 - These guidelines are intended to provide a description of ways in which pharmacists can improve access to health care, health promotion and the use of medicines on behalf of the patients they serve. The role of FIP is to provide leadership for na
...
Информационный бюллетень Июнь 2020 г.
Уязвимые группы населения в контексте ответных мер в отношении COVID-19
Vulnerable populations during COVID-19 response - Drug users
Approximately 80% of the 463 million adults worldwide with diabetes live in low-income and middle-income countries (LMICs). A major obstacle to designing evidence-based policies to improve diabetes outcomes in LMICs is the scarce availability of nationally representative data on the current patterns
...
Pharmacy Toolbox
recommended
Please find all relevant guidelines and information in our new Pharmacy Toolbox.
The PHARMACY TOOLBOX is a comprehensive knowledge repository to provide its users with practical, up-to-date information on medicines and good pharmaceutical practices. It collates basic documents on (essential) medici
...
Q 12: In children and adolescents with anxiety disorders, what is the effectiveness and safety, considering system issues in low- and middle-income countries, of using pharmacological interventions in non-specialist settings?
